IGMPI facebook Cannabis and Psychedelics Show Promise for Eating Disorder Relief: Study
IGMPI Logo
Centre for Nutrition and Dietetics Studies

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

18001031071 (Toll Free), +91 11 26512850
Regular | Online Live Classes Modes
Cannabis and Psychedelics Show Promise for Eating Disorder Relief: Study

Cannabis and Psychedelics Show Promise for Eating Disorder Relief: Study

A groundbreaking international study has revealed that people with eating disorders rate cannabis and psychedelics as the most effective substances for relieving symptoms—surpassing traditional prescription medications. Led by PhD student Sarah-Catherine Rodan at the University of Sydney, the survey involved over 7,600 participants across 83 countries. Respondents, mostly women with various eating disorders, reported that psilocybin and cannabis significantly alleviated symptoms, particularly in restrictive disorders like anorexia. Psychedelics were noted for long-lasting benefits, while prescription antidepressants, though helpful for general mental health, were less effective for eating-disorder symptoms. Alcohol, nicotine, and cocaine received the worst ratings. These findings have sparked clinical trials, including a psilocybin study for anorexia and a CBD pilot trial in young people. Researchers emphasize the urgent need for controlled clinical trials to validate these results and explore alternative treatment pathways, especially given the limited success of current therapies.

27-07-2025